![Chronic diseases no longer need to be lethal](https://globalpetindustry.com/wp-content/cache/thumb/84/1d7fdcd3be78784_960x540.png)
Pets are receiving a higher level of care than ever before, which means they’re much more likely to be diagnosed and treated for a lifetime pathology.
The increased level of care – combined with good nutrition – means that pets are living longer, making chronic diseases more likely. ‘Chronic disease’ is a catch-all term for any condition or illness that lasts for at least a year, but really it refers to diseases that are likely to last for the remainder of a pet’s life. These include heart conditions, kidney failure, epilepsy, atopic dermatitis, inflammatory bowel disease (IBD), and hormonal conditions like Cushing’s syndrome, hyperthyroidism and diabetes.
Prevalence of the pathology
In view of such a wide range of diseases, it perhaps isn’t surprising that there is no clear picture of just how many dogs and cats are affected by chronic disease, nor which species is most affected.
In 2013, North Carolina State University identified kidney disease as probably the most common chronic disease in pets, affecting as many as 1 in 2 cats. Some other studies suggest that the prevalence of kidney disease is higher in cats than in dogs.
Early diagnosis
For many of these conditions, early diagnosis is key to ensuring the pet lives a long and happy life despite the chronic disease. Modern medicine has allowed these chronic diseases to be named and classified; whereas once every dog with a skin condition was dismissed as having ‘mange’, many cases are now in fact identified as atopic dermatitis (allergies). Regular check-ups are essential in order to spot developing problems before symptoms become apparent, but it is even more important to keep up with regular medication.
Medication
For almost all chronic diseases, medication needs to be given regularly to keep the animal stable. Whether it concerns a dog with arthritis or a cat with high blood pressure, maintaining the drugs at the right dose for the pet is imperative. This means that drug development – especially using novel formulations – is one of the most important areas in chronic disease science. Liquid hyperthyroid medication and once-a-month injectable arthritis treatments have made a huge difference to the health and welfare of pets in the UK, for example.
Novel treatments
Work to develop new medicines is ongoing. As science continues to advance the knowledge of chronic diseases in pets, novel treatments could be announced at any moment that make certain diseases a thing of the past. It is important to remember, though, that there’s often a big difference between what is happening at the forefront of research and what is available as treatment.
Several studies need to confirm the same findings before drug and food development companies start working on providing a solution for pets in the real world. It is too soon to say whether choline will one day be prescribed to help feline obesity, for example. But based on the lessons learned from previous treatments for chronic disease, it is unlikely to be a magic bullet, even if it does one day become a recognized treatment option. It is more likely that, as with injections for canine atopy, it will become just one more weapon in the arsenal.
The role of telemedicine
No matter how brilliant the drug is, good medical control also requires regular monitoring, allowing doses to be tweaked as necessary to provide the best result.
Owners can use apps to log dose and response in order to monitor their pet’s health if they have a chronic disease, and this can provide essential information for the vet. Teleconsults are also useful for monitoring chronic diseases without needing to see an in-person vet, and they are likely to become increasingly commonplace in the future. This is a positive development, as repeated visits to the vet can be stressful and expensive, especially if travel to a referral- level specialist is necessary.
While chronic diseases are presenting more of a challenge than ever, advances in medicine mean that such diseases are no longer a life sentence and many pets can live long, happy lives without symptoms.
The latest articles
![Rebranding: Zooplus refreshes its logo](https://globalpetindustry.com/wp-content/uploads/2024/09/zooplus-rebrand.png)
Rebranding: Zooplus refreshes its logo
The Munich-headquartered online retailer has undergone a rebranding to show its commitment to growth, innovation and future-looking vision.
![Exclusive: The success of pet supplies in Tesco’s new UK marketplace](https://globalpetindustry.com/wp-content/uploads/2024/09/Tesco-online-marketplace.png)
Exclusive: The success of pet supplies in Tesco’s new UK marketplace
Britain’s largest supermarket chain shares its plans with GlobalPETS to add more suppliers to its pet section.
![US: Pet ownership returns to pre-pandemic levels](https://globalpetindustry.com/wp-content/uploads/2024/09/dog-with-the-US-flag.jpg)
US: Pet ownership returns to pre-pandemic levels
New APPA research highlights the high cost of keeping dogs and cats, including vet and boarding expenses.
Weekly newsletter to stay up-to-date
Discover what’s happening in the pet industry. Get the must-read stories and insights in your inbox.